These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21994313)

  • 1. Special issue on CNS experimental medicine.
    Dawson GR; Dourish CT; Goodwin GM
    J Psychopharmacol; 2011 Sep; 25(9):1145-7. PubMed ID: 21994313
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system drug development, basic, and clinical research: thinking outside the box.
    Klein DF; Glick ID; Shader RI
    J Clin Psychopharmacol; 2011 Oct; 31(5):553-4. PubMed ID: 21869701
    [No Abstract]   [Full Text] [Related]  

  • 3. Is pharma running out of brainy ideas?
    Miller G
    Science; 2010 Jul; 329(5991):502-4. PubMed ID: 20671165
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care?
    Hopkins MM; Martin PA
    Expert Rev Neurother; 2006 Dec; 6(12):1765-7. PubMed ID: 17181421
    [No Abstract]   [Full Text] [Related]  

  • 5. Validation of experimental medicine methods in psychiatry: the P1vital approach and experience.
    Dawson GR; Craig KJ; Dourish CT
    Biochem Pharmacol; 2011 Jun; 81(12):1435-41. PubMed ID: 21440531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peter Corr outlines Pfizer's approach to innovation, maximizing capabilities and delivering essential medicine. Interview by Steve Carney.
    Corr PB
    Drug Discov Today; 2005 Aug; 10(15):1017-20. PubMed ID: 16055016
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular imaging as a de-risking tool: coming into focus?
    Mullard A
    Nat Rev Drug Discov; 2013 Apr; 12(4):251-2. PubMed ID: 23535924
    [No Abstract]   [Full Text] [Related]  

  • 8. The extinction of drugs for clinical research: Can the ECNP medicines chest save them?
    Nutt D; Kilpatrick G; Hayes A
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):487-90. PubMed ID: 24508534
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trials in psychiatry: present status and prospects].
    Azorin JM; Belzeaux R; Adida M
    Encephale; 2016 Dec; 42(6S):S1. PubMed ID: 28236985
    [No Abstract]   [Full Text] [Related]  

  • 10. Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney.
    Unterbeck A
    Drug Discov Today; 2005 Feb; 10(3):165-8. PubMed ID: 15708528
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Trials in CNS--SMi's Seventh Annual Conference. 25-26 November 2008, London, UK.
    Sherwood D
    IDrugs; 2009 Feb; 12(2):84-6. PubMed ID: 19204879
    [No Abstract]   [Full Text] [Related]  

  • 12. New developments in neuroscience.
    Williams M
    Curr Opin Investig Drugs; 2003 Jan; 4(1):26-7. PubMed ID: 12625023
    [No Abstract]   [Full Text] [Related]  

  • 13. Many are called, yet few are chosen. Are neuropsychiatric clinical trials letting us down?
    McArthur R
    Drug Discov Today; 2011 Mar; 16(5-6):173-5. PubMed ID: 21163366
    [No Abstract]   [Full Text] [Related]  

  • 14. [On new mechanisms of action of centrally active drugs].
    Castrén E; Panula P
    Duodecim; 2003; 119(15):1487-95. PubMed ID: 14502828
    [No Abstract]   [Full Text] [Related]  

  • 15. Getting more mileage out of a tankful of new molecular entities?
    Cavalla D
    Drug Discov Today; 2004 Apr; 9(7):304-5. PubMed ID: 15037227
    [No Abstract]   [Full Text] [Related]  

  • 16. New directions for drug discovery.
    Spedding M
    Dialogues Clin Neurosci; 2006; 8(3):295-301. PubMed ID: 17117611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing early Go/No Go decisions in CNS drug development.
    Potter WZ
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):155-7. PubMed ID: 25537256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugmakers plow more resources into autism.
    Sheridan C
    Nat Biotechnol; 2013 May; 31(5):367-9. PubMed ID: 23657371
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulating pharmaceutical innovation in the EU.
    Annemans L; Cleemput I; Hulstaert F; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):235-9. PubMed ID: 21671690
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials in CNS--SMi's eighth annual conference.
    Kirk R
    IDrugs; 2010 Feb; 13(2):66-9. PubMed ID: 20127552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.